<?xml version="1.0" encoding="UTF-8"?><experiments api-version="3" api-revision="091015" version="3.0" revision="091015" total="1" total-samples="15" total-assays="15"><experiment><id>521895</id><accession>E-GEOD-12113</accession><secondaryaccession>GSE12113</secondaryaccession><name>Transcription profiling by array of human pancreatic tumours in xenografts to investigate the antitumor activity and molecular effects of the novel Hsp 90 Inhibitor, IPI-504, in pancreatic cancer</name><releasedate>2009-08-07</releasedate><lastupdatedate>2015-04-29</lastupdatedate><organism>Homo sapiens</organism><experimenttype>transcription profiling by array</experimenttype><experimentdesign>compound treatment design</experimentdesign><description><id/><text>Tumors from pancreatic cancer specimens obtained at surgery were used for efficacy testing and biologic analysis.  These tumors were s.c. explanted in xenograft models for subsequent treatment experiments. This study aimed to assess the antitumor activity of the Hsp90 inhibitor, IPI-504, in pancreatic cancer and to determine the biological effects of the agent. Experiment Overall Design: Five tumor samples were profiled in treated and untreated with IPI504.  Untreated samples were profiled in duplicate.  The overall design is to identify differentially expressed genes in IPI504 treated versus untreated.</text></description><provider><contact>Aik Choon Tan</contact><role>submitter</role><email>actan@jhu.edu</email></provider><bibliography><accession>18852131</accession><authors>Song D, Chaerkady R, Tan AC, Garcia-Garcia E, Nalli A, Suarez-Gauthier A, Lopez-Rios F, Zhang XF, Solomon A, Tong J, Read M, Fritz C, Jimeno A, Pandey A, Hidalgo M.</authors><title>Antitumor activity and molecular effects of the novel heat shock protein 90 inhibitor, IPI-504, in pancreatic cancer.</title><status>published</status></bibliography><samplecharacteristic><category>clinical history</category><value>tumor xenografted in six-week-old female athymic nude mouse</value></samplecharacteristic><samplecharacteristic><category>disease</category><value>pancreatic cancer</value></samplecharacteristic><samplecharacteristic><category>organism</category><value>Homo sapiens</value></samplecharacteristic><samplecharacteristic><category>organism part</category><value>pancreas</value></samplecharacteristic><experimentalvariable><name>compound</name><value>IPI504</value><value>vehicle</value></experimentalvariable><arraydesign><id>11119</id><accession>A-AFFY-44</accession><name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name><count>15</count><legacy_id>405156763</legacy_id></arraydesign><protocol><id>51</id><accession>P-AFFY-6</accession></protocol><protocol><id>1124929</id><accession>P-G12113-1</accession></protocol><protocol><id>1124930</id><accession>P-G12113-2</accession></protocol><bioassaydatagroup><id/><name>rawData</name><bioassaydatacubes>15</bioassaydatacubes><arraydesignprovider/><dataformat>rawData</dataformat><bioassays>15</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>scan</name><bioassaydatacubes>15</bioassaydatacubes><arraydesignprovider/><dataformat>scan</dataformat><bioassays>15</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>processedDataMatrix</name><bioassaydatacubes>1</bioassaydatacubes><arraydesignprovider/><dataformat>processedDataMatrix</dataformat><bioassays>1</bioassays><isderived>1</isderived></bioassaydatagroup></experiment></experiments>